S_qy Overall, the causative APC mutation has been identified in only 30% of the patients with familial adenomatous polyposis (FAP) (Murday et al., 1989) . The clinical manifestations of FAP are a result of mutations in APC, a gene located on chromosome 5q21-q22 and for which the entire coding sequence is now known (Groden et al., 1991; Kinzler et al., 1991; Nishishio et al., 1991). Nonethekss, of over 800 FAP patients reported in the world literature, the overall frequency of identifying the causative mutation is only 30% (Nagase et al., 1992a; Nagase & Nakamura, 1993; Mandl et al., 1994) and ranges from 21% (Mandl et al., 1994) to 67% (Nagase et al., 1992a). This may reflect any one or more of the following: the selection criteria for the diagnosis of FAP, the sensitivity and robustness of the mutation detection technique employed, the assiduousness of the search for mutations, the presence of causative gene alterations influencing APC expression outwith the coding sequence and the possibility of genetic heterogeneity in FAP.
Familial adenomatous polyposis (FAP) is an autosomal dominant heritable disorder with a population frequency of around 1:7,000. Penetrance is almost 100% and the syndrome is characterised by the development of hundreds or thousands of colorectal polyps during the second decade of life. The presence of more than 100 adenomatous polyps is diagnostic of FAP. Progression of one or more of the polyps to carcinoma is almost inevitable unless prophylactic surgical excision of the large bowel is performed (Murday et al., 1989) . The clinical manifestations of FAP are a result of mutations in APC, a gene located on chromosome 5q21-q22 and for which the entire coding sequence is now known (Groden et al., 1991; Kinzler et al., 1991; Nishishio et al., 1991) . Nonethekss, of over 800 FAP patients reported in the world literature, the overall frequency of identifying the causative mutation is only 30% (Nagase et al., 1992a; Nagase & Nakamura, 1993; Mandl et al., 1994) and ranges from 21% (Mandl et al., 1994) to 67% (Nagase et al., 1992a) . This may reflect any one or more of the following: the selection criteria for the diagnosis of FAP, the sensitivity and robustness of the mutation detection technique employed, the assiduousness of the search for mutations, the presence of causative gene alterations influencing APC expression outwith the coding sequence and the possibility of genetic heterogeneity in FAP.
Presymptomatic colonic screening of at-risk relatives and appropriate prophylactic surgery considerably reduces morbidity and mortality from FAP (Jarvinen, 1992 (Groden et al.. 1991 (Orita et al.. 1989; Groden et al.. 1991) . PCR products were denatured and run on 6% polyacrylamide gels with 10% glycerol at room temperature under non-denaturing conditions. Gels were dried and autoradiographv performed for 6-24 h.
Heteroduplex analysis PCR amplification of all APC fragments was camred out as described for SSCP analysis and heteroduplex analysis performed as described (Nagamine et al.. 1989) . Autoradiographs were assessed after 6-24 h).
Protein truncation test (PTT) PCR amplification was used to introduce the 17 bp consensus T7 promoter sequence and a mammalian translation initiation sequence in-frame with unique APC sequence as previously described (Powell et al.. 1993) . Unique primers for most of exon 15 were as described by Powell et al. (segments 3-5). but we modified primers for exons 1-14 in order to analyse cDNA templates for exons 1-14 in two overlapping reactions. We also designed the forward primer for the most 5' part of exon 15 to be closer to the splice site. Therefore. a total of six forward primer sets were designed in the following way: T7 consensus promoter sequence-spacer-Kozak consensus sequence-ATG-unique APC sequence in-frame with the ATG in order to allow overlapping fragments of the entire gene when suitable reverse primers from the published sequences (Groden et al.. 1991) were selected.
Exons 1-14 were amplified from cDNA which had been reverse transcribed from lyphoblastoid cell line RNA using a two-stage nested PCR technique with the internal primer bearing the T7 promoter and initiation sequences. Primer sequences used in the PTT are shown in Table II We were unable to detect any alteration in the APC gene in one FAP patient (MD129). The kindred of this patient was relatively small and DNA was not retrievable from some deceased family members. However, linkage analysis using intragenic APC polymorphisms achieved a peak lod score of 1.69 at 0 = 0.0, thereby substantially excluding the possibility of another non-Sq-linked locus being involved. HOT analysis had shown no heterozygosity at any of the known APC polymorphic sites even though more than 20 intragenic restriction site polymorphisms (summarised by Nagase et al.. 1992h) were screened. In addition. flanking linked markers EF544 and L562 (Dunlop et al.. 1990) showed no heterozygosity and a 3' PCR-amplifiable SspI polymorphism (Heighway et al.. 1991 ) was found to be homozygous. SSCP and heteroduplex analysis of each segment of APC in patient MD129 also failed to reveal any mutation or polymorphisms.
In view of the persisent evidence of homozygosity at every locus examined. we considered whether the patient might be hemizygous at the APC locus. Karyotype analysis of Gbanded chromosome spreads from peripheral lymphocytes identified two normal chromosome 5 homologues. Therefore. fluorescent in situ hybridisation (FISH) was carried out using cosmids that map to the APC locus (ym75 maps within the Kozak initiation sequence and methionine was as described by Roest et al. (1993) . 5'-GGATCCTAATACGACTCACTATAGGAACAGACCACCATG-3'. and is referred to for each primer as T7 promoter + Kozak + ATG. Figure 1 Sequence of each of the nine mutations found. In each case the mutant and wild-type sequence can be seen as double-stranded DNA was sequenced directly from PCR amplification products as described (Winship. 1989 (Figure 3a  and b) .
Finally, we sequenced the first three exons of APC and intron-exon boundaries (excluding the sequences 5' of exon 1 as this was not fully characterised) because the very small PCR fragments and resultant protein products generated by the PT-T could have been degraded or lost during analysis. However, no sequence variations were noted from published sequence or from our control DNAs.
We have studied ten kindreds with a secure clinical and pathological diagnosis of FAP. each of which was known to be linked to chromosome 5q21. The causative mutation was detected in nine of these families, but despite extensive study we were unable to identify the mutation in the remaining patient. The peak lod score of 1.69 with no recombinants in the family strongly suggests that dysfunction of APC is the undelying moleular lesion in this kindred. However, our studis indicate that there is no mutation in the coding sequence and APC splicing is normal. In the published literature, there is little evidence of clustering of APC mutations with only a few mutations (4 or 5 bp deletions at codons 1,061 and 1,309) being at all common, and together accounting for around 10% of all published mutations. Furthermore, since the reported mutations in the APC gene are scattered across the gene (Nagase & Nakamura 1993) , it is apparent that the entire coding region will require screening in a proportion of patients. The two main screening techniques used here, namely HOT analysis and PFT, are complementary. We initially set out to screen APC using the HOT technique, an extremely eff&ient method of mutation detection. However, we now feel that a combination of analysis by FTT with follow-up by HOT is optimal. The FIT technique applied here is ideal to screen 1-2 kb of cDNA or a single large exon of genomic DNA since essentially all causative APC mutations result in premature stop codons. The entire gene can be screened in just six overlapping PCR reactions from cDNA templates. The demonstration of truncation of in vitro synthesised APC product is defacto evidence that the mutation is due to a premature stop codon. 100% of mutations (Condie et al., 1993) , it is also labour intensive when employed to analyse a gene such as APC at the DNA level. Although it may be an unattractive technique to screen substantial numbers of FAP patients, it is particularly useful for back-up screening when other methods of mutation detection, such as SSCP and heteroduplex analysis have failed. This would best be done by analysis of 1 kb cDNA templates generated by RT-PCR. It is desirable to characterise the mutation by DNA sequencing, as this may then allow use of a simple restriction digest for predictive testing of at-risk individuals in whom the mutation alters a restriction site.
It has been suggested that mutations occurring towards the 5' part of the gene have an attenuated phenotype, while those at the 3' end are more severe (Nagase et al., 1992b; Groden et al., 1993; Spiro et al., 1993) . While our primary aim was to assess and develop an APC mutation screning strategy in a relatively small number of patients, the data presented here support the apparent association of attenuated phenotype FAP with mutations in exons 3 and 4 (Spiro et al., 1993 possibility that this family represent a FAP phenocopy but we consider this highly unlikely since all clinical and pathological data point to a diagnosis of polyposis coli and genetic linkage analysis strongly supports the involvement of APC. The most likely explanation of our findings is that there may be a promoter mutation influencing expression of APC. It will be of interest to screen the APC promoter in this patient once this region is fully characterised.
